Barrier Islands Psychiatry

What Barrier Islands Psychiatry does

Barrier Islands Psychiatry is a private outpatient psychiatric and addiction medicine practice headquartered in Charleston, South Carolina, operating from two adjacent buildings on Ashley River Road. The practice delivers a comprehensive suite of mental health and substance use services, including psychiatric assessment and medication management, individual and group therapy modalities (CBT, DBT, psychodynamic, ACT), specialty interventional treatments (NeuroStar TMS for Major Depressive Disorder, Spravato/esketamine for Treatment-Resistant Depression), an Intensive Outpatient Program (IOP) using DBT, and Osteopathic Manipulative Therapy (OMT) for chronic pain and addiction recovery. Additional addiction services include Suboxone and Sublocade medication-assisted treatment, Vivitrol, alcohol/benzodiazepine/drug detox, and pharmacogenetic testing to inform medication selection. The clinical team includes roughly 15 providers — board-certified psychiatrists (MD, DO), physician assistants (PA-C), and licensed therapists (PhD, LPC-S, LISW, LCSW) — providing both in-person and telehealth services.

The business model is direct-to-consumer fee-for-service psychiatric care funded primarily through commercial insurance billing, with patient responsibility collected via copays, deductibles, and out-of-pocket payments at the time of service. Revenue streams are diversified across recurring psychiatric medication management visits, structured multi-week specialty protocols (TMS, Spravato, IOP), and ongoing medication-assisted treatment for opioid and alcohol use disorders. The practice supplements patient acquisition through local SEO, an educational blog, Google reviews, and a referral relationship with Palmetto Lowcountry Behavioral Health for inpatient care coordination. The practice has served 1,550+ patients historically and accepts most major commercial insurance plans plus HSA/FSA payments, with a $75 charge for after-hours non-emergency calls to existing patients.

Name

Barrier Islands Psychiatry

Legal name

Barrier Islands Psychiatry

Website

https://barrierislandspsychiatry.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Barrier Islands Psychiatry is a private outpatient psychiatric and addiction medicine practice in Charleston, SC, serving individual patients with medication management, therapy, TMS, Spravato, Suboxone treatment, IOP, and OMT delivered by 15 specialized providers.

Ownership category

akta.pro rank

Product category

Outpatient Mental Health & Addiction Medicine

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

akta.pro secondary industry

Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)

Keywords

• Outpatient psychiatry services
• Addiction medicine treatment
• Mental health therapy
• Medication management
• Intensive outpatient program

Headquarters

HQ city

Charleston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Psychiatric and Medical Services Revenue: The practice generates revenue through billable psychiatric assessments, medication management, psychotherapy, and medical treatments. Services are billed to insurance or paid out-of-pocket at time of service. Accepts most major commercial insurance plans.
2. Intensive Outpatient Program (IOP): Structured substance abuse treatment program using DBT. Revenue generated through insurance billing for group therapy sessions and related services.
3. Specialty Treatments (TMS, Spravato): Revenue from FDA-approved specialty treatments for treatment-resistant depression. Typically covered by health insurance plans.
4. Suboxone/Addiction Treatment Program: Medication-assisted treatment for opioid addiction including Suboxone prescriptions and addiction counseling services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Barrier Islands Psychiatry is an outpatient psychiatric and addiction medicine practice in Charleston, SC that provides psychiatric assessment, evidence-based medication management, individual and group therapy, and an Intensive Outpatient Program (IOP) using Dialectical Behavior Therapy. The practice also delivers specialty FDA-approved treatments including NeuroStar TMS for major depressive disorder, Spravato (esketamine) for treatment-resistant depression, Suboxone/Sublocade programs for opioid use disorder, Vivitrol, medical detox, pharmacogenetic testing, and Osteopathic Manipulative Therapy, available via in-person visits and telehealth.

Product overview

Barrier Islands Psychiatry is an outpatient psychiatric and addiction medicine practice in Charleston, SC, offering a comprehensive suite of mental health treatment services. The core offerings include Medication Management for psychiatric disorders and addictions, specialized addiction treatment programs (Suboxone, Sublocade, Vivitrol, and detox services), interventional psychiatric treatments (NeuroStar TMS and Spravato), Intensive Outpatient Program (IOP) using DBT, individual and group therapy, and Osteopathic Manipulative Therapy. The practice integrates psychiatric assessment, medication management, and various therapy modalities to treat conditions including depression, anxiety, PTSD, ADHD, bipolar disorder, and substance use disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• Medication Management Prescribing and regulating medications for psychiatric disorders and addictions, including alcohol and opioid addiction, anxiety, depression, ADHD, bipolar disorder, PTSD, and schizophrenia, provided by psychiatrists and physician assistants.
• Transcranial Magnetic Stimulation (TMS) Non-drug NeuroStar TMS treatment for Major Depressive Disorder that uses magnetic pulses to stimulate the left prefrontal cortex, with daily 19-37 minute sessions over approximately 6 weeks.
• Spravato Treatment FDA-approved esketamine nasal spray for Treatment-Resistant Depression, administered as weekly in-office 2-hour monitored sessions for 8 weeks, targeting the NMDA receptor.
• Suboxone Treatment Program Comprehensive outpatient Suboxone (buprenorphine/naloxone) program for opioid dependence with induction, restart, relapse prevention groups, and individual therapy for co-occurring disorders.
• Intensive Outpatient Program (IOP) Substance abuse treatment using evidence-based Dialectical Behavior Therapy, meeting three hours a day for three days a week, incorporating art therapy, equine therapy, music therapy, nutrition education, and yoga with a family support component.
• Group Therapy Therapist-led groups for addiction and general psychiatry, including a Grief Processing Group, Relapse Prevention Group, and various other support groups.
• Individual Therapy One-on-one therapy using evidence-based approaches including cognitive-behavioral therapy, psychodynamic therapy, and mindfulness-based therapy to explore thoughts, emotions, and behaviors.
• Osteopathic Manipulative Therapy (OMT) Non-pharmacological hands-on treatment for chronic pain and addiction recovery that addresses musculoskeletal deficits and activates the parasympathetic nervous system, offered by Dr. Spencer for headaches, vertigo, nerve pain, TMJ, and chronic pain.
• Psychiatric Assessment and Treatment Comprehensive psychiatric evaluation and evidence-based treatment that diagnoses the cause of psychiatric disorders and restores normal brain circuit functions through medications, therapy, and holistic health approaches.
• Sublocade FDA-approved injectable buprenorphine medication for opioid use disorder, administered as part of the practice's addiction treatment program.
• Alcohol, Benzodiazepine, and Drug Detox Medical detox services for alcohol, benzodiazepine, and drug addictions delivered as part of the practice's comprehensive addiction treatment offerings.
• Vivitrol (naltrexone) Medication-assisted treatment using naltrexone to reduce cravings and support recovery from alcohol and opioid addiction.
• Pharmacogenetic Testing Genetic testing to inform medication selection and dosing based on individual genetic profiles for more personalized psychiatric treatment.

Quantifiable outcome

• 1550+ patients served (Happy Clients metric)
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

One partnership is on record.

• Palmetto Lowcountry Behavioral HealthminorOthersReferral partner for inpatient psychiatric hospitalization when patients require 24/7 care or crisis stabilization. Barrier Islands Psychiatry coordinates care with this facility for seamless recovery transitions. No doctor referral needed for their services (patients can self-present). Contact: 843-747-5830.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cerebral: Cerebral is a large telehealth platform providing medication management and therapy for anxiety, depression, and ADHD. Comparable as a broader incumbent in online outpatient psychiatry and a competitive threat to Barrier Islands Psychiatry's medication management and telehealth services.
• Talkiatry: Talkiatry is an in-network telepsychiatry practice staffed by board-certified psychiatrists providing medication management for depression, anxiety, ADHD, and related conditions. Comparable as a scaled outpatient psychiatry operator directly competing for the same patient population.

Direct peers

• Groups Recover Together: Groups Recover Together runs an outpatient Suboxone (buprenorphine) program for opioid use disorder with group therapy and medication management. Directly comparable to Barrier Islands Psychiatry's Suboxone treatment program and relapse-prevention group therapy.
• Two Chairs: Two Chairs operates in-person and virtual outpatient therapy practices with multiple California locations. Comparable as a multi-provider outpatient mental health practice combining individual therapy, psychiatry, and specialty treatment tracks.
• Workit Health: Workit Health provides online Suboxone treatment and virtual addiction care with medication-assisted treatment plus therapy. Comparable in the MAT/Suboxone + therapy delivery model and in serving patients with opioid and alcohol use disorders.
• Brightside Health: Brightside Health is a telehealth psychiatry platform specializing in depression and anxiety treatment, including medication management and therapy. Comparable as a tech-enabled outpatient psychiatry practice competing for the same anxiety/depression patient base, including those with treatment-resistant presentations.
• Eleanor Health: Eleanor Health operates outpatient addiction and mental health clinics offering MAT, therapy, and recovery support. Comparable as a multi-site outpatient provider integrating addiction medicine with psychiatry in a community-clinic setting.
• Charlie Health: Charlie Health operates a virtual Intensive Outpatient Program (IOP) for teens and young adults with mental health and substance use conditions. Comparable as a tech-enabled outpatient behavioral health provider running structured IOP programs — directly overlapping Barrier Islands Psychiatry's DBT-based IOP service line.

Others

• NeuroStar (Neuronetics): Neuronetics manufactures the NeuroStar TMS device used by Barrier Islands Psychiatry for treatment-resistant depression. Included as a technology/equipment partner whose broader provider network defines a peer group of TMS-offering outpatient psychiatry practices.
• Spravato / Janssen CarePath (Johnson & Johnson): Spravato (esketamine) is an FDA-approved nasal spray for treatment-resistant depression marketed by Janssen. Barrier Islands Psychiatry is part of the certified Spravato REMS provider network; the broader REMS provider community forms an indirect peer group for treatment-resistant depression services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Barrier Islands Psychiatry